Third phase 3 trial shows HEPLISAV-B ... - HFI Connect - Hep...
Third phase 3 trial shows HEPLISAV-B vaccine safe, effective against HBV
Written by
HFIAdmin
To view profiles and participate in discussions please or .
1 Reply
•
Sadly in the UK only 0.5% of children access any type of HBV vaccine, we met the providers of this vaccine in London once and still our nation is last on Earth at HBV vaccinating and general viral hepatitis screening. With prisons supplying the bulk of UK blood 1945 to 1986 an entire generation is still completely unwarned and untested as are all our migrants from countries with high HBV and HCV prevalences